CannaVcell Naturally Produces Cannabis' Active Ingredients Without Growing the Plant Itself
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2019) - CannaVcell Sciences Inc. (CSE: CNVC) ("CannaVcell") announced last Thursdays, the first production of Cannabis cells in suspension, with a cannabinoid profile identical to that of the original cannabis plant - without the need to grown the plant itself. The achievement was possible using the breakthrough and patented BioHarvest's technology (CannaVcell is the worldwide exclusive licensee of the technology for cannabis...
2019-09-30 10:00 AM EDT
CannaVcell Announces Stable Production of Cannabis Cells, Trichomes, and Cannabinoids Without the Need to Grow the Cannabis Plant Itself
Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - Using breakthrough proprietary and patented technology developed by BioHarvest Ltd, CannaVcell (CSE: CNVC) (the worldwide exclusive licensee of this technology for Cannabis applications) is announcing today the first ever production of Cannabis cells in suspension, with a cannabinoid profile identical to that of the source plant - without the need to grow the plant itself. This represents the successful completion of the...
2019-09-26 9:00 AM EDT
Canna-V-Cell Sciences Inc., Announces Significant Milestone
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") announces today it has reached a significant milestone of having Cannabis trichomes at the suspension phase. "This clearly confirms that the progress made to-date towards the completion of the 16 months development program has exceeded the expectations" said Dr. Yochi Hagay CTO of CannaVcell and added " we can now be a
2019-08-26 9:00 AM EDT
CORRECTION FROM SOURCE: Canna-V-Cell Sciences Inc. Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "Company") issued the following news release to amend its news release of August 13, 2019 to correct an error in the term of the warrants. The Company announces that the Company intends to complete a private placement of up to 6,666,667 units at a price $0.15 per unit for total proceeds of up to $1,000,000. Each unit will consist of one common share of the Company and one...
2019-08-14 8:30 AM EDT
Canna-V-Cell Sciences Inc. Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "Company") announces that the Company intends to complete a private placement of up to 6,666,667 units at a price $0.15 per unit for total proceeds of up to $1,000,000. Each unit will consist of one common share of the Company and one non-transferable share purchase warrant. Each warrant will be exercisable to purchase an additional common share at a price of $.30 per share for a...
2019-08-13 8:11 PM EDT
Canna-V-Cell Sciences Inc. July 9th, 2019: Shareholders Letter
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2019) - I am happy to have this opportunity to write my first opened letter addressed to you, the shareholders of Canna-V-Cell (CSE: CNVC). As you all know, we started our journey in October of last year with the major task of adapting the breakthrough proprietary and patented biofarming technology to Cannabis. Biofarming enables the production of all the active ingredients without growing the plant itself. So far, we have been following...
2019-07-09 10:57 AM EDT
CannaVcell enhances its IR activities by hiring INN and Flinnwest services
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") With the increase in its confidence of achieving the goals of the Cannabis biofarming development program, CannaVcell is hiring both Flinnwest and INN services. "This increase in confidence requires a further enhancement in the communication with the investment community" said Dr. Zaki Rakib the CEO while adding "as we are getting closer to demonstrate the feasibility and...
2019-06-25 9:00 AM EDT
Canna-V-Cell Increases Confidence in Its Biofarming Technology by Growing Cannabis Trichomes Containing Active Cannabinoids at the Callus Level
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (The "Company"), Canna-V-Cell is announcing today that as part of its program of applying the biofarming technology to Cannabis, it has achieved the critical milestone of ensuring the existence of active cannabinoids ingredients in its bank of cells required for the next step in the biofarming process. Active cannabinoids exist in the trichomes of the Cannabis plant. Trichomes, especially the...
2019-05-28 9:00 AM EDT
Canna-V-Cell Sciences Inc. announces Israel health ministry approval
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2018) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "CannaVcell") CannaVcell, in its aim to develop and produce Cannabis active ingredients on the basis of the biofarming technology, is announcing that it has received through its subsidiary in Israel, the authorization of the health ministry of Israel to conduct research and development with Cannabis plants. "This is a major milestone in the adaptation of the cell growth technology...
2018-11-19 8:30 AM EST